162 related articles for article (PubMed ID: 23674856)
1. ABO blood type, long-standing diabetes, and the risk of pancreatic cancer.
Egawa N; Lin Y; Tabata T; Kuruma S; Hara S; Kubota K; Kamisawa T
World J Gastroenterol; 2013 Apr; 19(16):2537-42. PubMed ID: 23674856
[TBL] [Abstract][Full Text] [Related]
2. ABO Blood Group and Diabetes Mellitus Influence the Risk for Pancreatic Cancer in a Population from China.
Li X; Xu H; Gao P
Med Sci Monit; 2018 Dec; 24():9392-9398. PubMed ID: 30582832
[TBL] [Abstract][Full Text] [Related]
3. ABO blood group and the risk of pancreatic cancer.
Wolpin BM; Chan AT; Hartge P; Chanock SJ; Kraft P; Hunter DJ; Giovannucci EL; Fuchs CS
J Natl Cancer Inst; 2009 Mar; 101(6):424-31. PubMed ID: 19276450
[TBL] [Abstract][Full Text] [Related]
4. Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study.
Woo SM; Joo J; Lee WJ; Park SJ; Han SS; Kim TH; Koh YH; Kim HB; Hong EK
J Korean Med Sci; 2013 Feb; 28(2):247-51. PubMed ID: 23400555
[TBL] [Abstract][Full Text] [Related]
5. Two different types of diabetes mellitus in pancreatic cancer population. Comparative study between new onset and long standing diabetes mellitus on 76 patients with pancreatic cancer.
Tanţău A; Negrean V; Alexescu T; Para I; Tărmure S; Casoinic F; Sâmpelean D; Mocanu T; Tanţău M
Rom J Intern Med; 2014; 52(1):18-23. PubMed ID: 25000673
[TBL] [Abstract][Full Text] [Related]
6. Significant association between ABO blood group and pancreatic cancer.
Greer JB; Yazer MH; Raval JS; Barmada MM; Brand RE; Whitcomb DC
World J Gastroenterol; 2010 Nov; 16(44):5588-91. PubMed ID: 21105191
[TBL] [Abstract][Full Text] [Related]
7. ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer.
Li D; Pise MN; Overman MJ; Liu C; Tang H; Vadhan-Raj S; Abbruzzese JL
Cancer Med; 2015 Nov; 4(11):1651-8. PubMed ID: 26275671
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.
Wolpin BM; Kraft P; Gross M; Helzlsouer K; Bueno-de-Mesquita HB; Steplowski E; Stolzenberg-Solomon RZ; Arslan AA; Jacobs EJ; Lacroix A; Petersen G; Zheng W; Albanes D; Allen NE; Amundadottir L; Anderson G; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Clipp S; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs K; Kooperberg C; Lynch SM; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Rajkovic A; Sanchéz MJ; Shu XO; Slimani N; Thomas G; Tobias GS; Trichopoulos D; Vineis P; Virtamo J; Wactawski-Wende J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
Cancer Res; 2010 Feb; 70(3):1015-23. PubMed ID: 20103627
[TBL] [Abstract][Full Text] [Related]
9. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival.
El Jellas K; Hoem D; Hagen KG; Kalvenes MB; Aziz S; Steine SJ; Immervoll H; Johansson S; Molven A
Cancer Med; 2017 Jul; 6(7):1531-1540. PubMed ID: 28556564
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of CA 19-9 for pancreatic cancer screening in patients with new-onset diabetes.
Choe JW; Kim HJ; Kim JS; Cha J; Joo MK; Lee BJ; Park JJ; Bak YT
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):263-268. PubMed ID: 29752133
[TBL] [Abstract][Full Text] [Related]
11. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer.
Wang DS; Chen DL; Ren C; Wang ZQ; Qiu MZ; Luo HY; Zhang DS; Wang FH; Li YH; Xu RH
Int J Cancer; 2012 Jul; 131(2):461-8. PubMed ID: 21858814
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age.
Mizuno S; Nakai Y; Isayama H; Yanai A; Takahara N; Miyabayashi K; Yamamoto K; Kawakubo K; Mohri D; Kogure H; Sasaki T; Yamamoto N; Sasahira N; Hirano K; Tsujino T; Ijichi H; Tateishi K; Akanuma M; Tada M; Koike K
J Gastroenterol; 2013 Feb; 48(2):238-46. PubMed ID: 22735942
[TBL] [Abstract][Full Text] [Related]
13. Difference of Risk of Pancreatic Cancer in New-Onset Diabetes and Long-standing Diabetes: A Population-based Cohort Study.
Lee HS; Chae W; Sung MJ; Keum J; Jo JH; Chung MJ; Park JY; Park SW; Song SY; Park EC; Nam CM; Jang SI; Bang S
J Clin Endocrinol Metab; 2023 May; 108(6):1338-1347. PubMed ID: 36548964
[TBL] [Abstract][Full Text] [Related]
14. Influence of Cancer Susceptibility Gene Mutations and ABO Blood Group of Pancreatic Cancer Probands on Concomitant Risk to First-Degree Relatives.
Antwi SO; Rabe KG; Bamlet WR; Meyer M; Chandra S; Fagan SE; Hu C; Couch FJ; McWilliams RR; Oberg AL; Petersen GM
Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):372-381. PubMed ID: 34782396
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma.
Malleo G; Mazzarella F; Malpaga A; Marchegiani G; Salvia R; Bassi C; Butturini G
Surgery; 2013 May; 153(5):641-50. PubMed ID: 23276391
[TBL] [Abstract][Full Text] [Related]
16. Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.
He XY; Li JF; Yao WY; Yuan YZ
Ann Surg Oncol; 2013 Nov; 20(12):3809-16. PubMed ID: 23943021
[TBL] [Abstract][Full Text] [Related]
17. ABO blood type, diabetes and risk of gastrointestinal cancer in northern China.
Gong Y; Yang YS; Zhang XM; Su M; Wang J; Han JD; Guo MZ
World J Gastroenterol; 2012 Feb; 18(6):563-9. PubMed ID: 22363124
[TBL] [Abstract][Full Text] [Related]
18. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study.
Ben Q; Cai Q; Li Z; Yuan Y; Ning X; Deng S; Wang K
Eur J Cancer; 2011 Jan; 47(2):248-54. PubMed ID: 20709528
[TBL] [Abstract][Full Text] [Related]
19. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
Lee S; Hwang HK; Kang CM; Lee WJ
Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
[TBL] [Abstract][Full Text] [Related]
20. The role of blood groups in the development of diabetes mellitus after gestational diabetes mellitus.
Karagoz H; Erden A; Ozer O; Esmeray K; Cetinkaya A; Avci D; Karahan S; Basak M; Bulut K; Mutlu H; Simsek Y
Ther Clin Risk Manag; 2015; 11():1613-7. PubMed ID: 26527878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
